Remove Depo-Medrol from ophthalmological surgical suites to avoid accidental retinal toxicity

Methylprednisolone acetate, which has similar packaging and appearance to triamcinolone acetonide, should be removed from shelves of ophthalmological surgical suites because intraocular use can lead to irreversible retinal necrosis and permanent vision loss.
“Depo-Medrol is nearly identical in physical appearance to triamcinolone acetonide but toxic to the retina and potentially blinding so should absolutely never be used in the eye,” Michael D. Ober, MD, one of the study’s co-authors, told
A single case study examined the records of a 68-year-old man who

Full Story →